サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1321652

エクソソーム研究製品の世界市場

Exosome Research Products
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 93 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
エクソソーム研究製品の世界市場
出版日: 2023年08月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

エクソソーム研究製品の世界市場は2030年までに11億米ドルに達する

COVID-19後のビジネス環境が変化する中、2022年に2億4,310万米ドルと推定されるエクソソーム研究製品の世界市場は、2030年には11億米ドルに達すると予測され、2022年から2030年にかけて21.2%のCAGRで成長すると予測されます。本レポートで分析したセグメントの一つであるキット＆試薬は、CAGR23.4％を記録し、分析期間終了時には6億2,940万米ドルに達すると予測されています。現在進行中のパンデミック後の回復を考慮し、機器セグメントの成長は今後8年間のCAGRを20.7％に修正しました。

米国市場は7,260万米ドル、中国はCAGR 20.5％で成長すると予測

米国のエクソソーム研究製品市場は、2022年には7,260万米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年までの分析期間においてCAGR 20.5%で推移し、2030年までに1億9,330万米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ18.6%と17%の成長が予測されています。欧州では、ドイツがCAGR約13%で成長すると予測されています。

調査対象企業の例

  • AMS Biotechnology Ltd.
  • Bio-Techne
  • Lonza Group AG
  • Miltenyi Biotech
  • Nanosomix
  • Norgen Biotek Corp.
  • NX Pharmagen
  • Qiagen N.V.
  • System Biosciences（SBI）
  • Thermo Fisher Scientific Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP21745

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Exosome Research Products Market to Reach $1.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Exosome Research Products estimated at US$243.1 Million in the year 2022, is projected to reach a revised size of US$1.1 Billion by 2030, growing at aCAGR of 21.2% over the period 2022-2030. Kits & Reagents, one of the segments analyzed in the report, is projected to record 23.4% CAGR and reach US$629.4 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 20.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $72.6 Million, While China is Forecast to Grow at 20.5% CAGR

The Exosome Research Products market in the U.S. is estimated at US$72.6 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$193.3 Million by the year 2030 trailing a CAGR of 20.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.6% and 17% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13% CAGR.

Select Competitors (Total 42 Featured) -

  • AMS Biotechnology Ltd.
  • Bio-Techne
  • Lonza Group AG
  • Miltenyi Biotech
  • Nanosomix
  • Norgen Biotek Corp.
  • NX Pharmagen
  • Qiagen N.V.
  • System Biosciences (SBI)
  • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Exosome Research Products - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Exosome Research Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Exosome Research Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Clinical Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Hospitals & Clinical Testing Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Lung Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 20: World 8-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Colorectal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 22: World 8-Year Perspective for Colorectal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 24: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 25: World Exosome Research Products Market Analysis of Annual Sales in US$ for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 29: USA 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 31: USA 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Canada 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Canada 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • JAPAN
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 41: Japan 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Japan 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • CHINA
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 47: China 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 49: China 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • EUROPE
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe 8-Year Perspective for Exosome Research Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Europe 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Europe 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • FRANCE
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 59: France 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 61: France 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 63: France 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • GERMANY
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Germany 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Germany 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Germany 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Italy 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 73: Italy 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Italy 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • UNITED KINGDOM
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 77: UK 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 79: UK 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 81: UK 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Rest of World 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 97: Rest of World 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of World 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030

IV. COMPETITION